You searched for "diagnostic"

1669 results found

Standby for standards: Ophthalmic imaging

The Ophthalmic Imaging Associating (OIA) will propose and publish a volume of refined standards for Ophthalmic and Vision Science. These will be reviewed by the OIA membership at its annual conference in November 2025 and released thereafter. The OIA is...

Newmedica welcomes GIRFT glaucoma guidance but calls for equitable commissioning to protect patient access

Newmedica has welcomed the publication of NHS England’s Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services, recognising it as an important step toward improving consistency and outcomes for patients across England. The guidance’s emphasis on patient...

Neurofibromatosis type 1 features

The aim in this study was to identify the incidence and de nova mutation rate of Neurofibramatosis type 1 (NF1) and describe the ocular and non-ocular findings in a population-based cohort of patients diagnosed over a 30-year period. The study...

Pseudostrabismus leading to strabismus

The authors aimed to evaluate the incidence of strabismus in children initially diagnosed with pseudostrabismus and identify risk factors for development of strabismus. This was a retrospective review of 65 patients with a diagnosis of pseudostrabismus; two exo and 63...

The risk factors associated with isolated microvascular third nerve palsy

The authors used the Rochester Epidemiology Project for this retrospective case review of third nerve palsy. Inclusion criteria was adults >18 years, with new onset isolated microvascular third nerve palsy diagnosed within a 36-month period, with recovery or significant improvement,...

Leicester Community Eye Hospital recognised as ‘Good’

Care and Quality Commission awards CHEC coveted quality rating.

PREVIEW: International SPECTRALIS Symposium – AND BEYOND

The International SPECTRALIS Symposium (ISS) marks its 21st anniversary with an exciting new chapter in Heidelberg, Germany, just steps away from the headquarters of Heidelberg Engineering. Recognised as one of the most prestigious scientific imaging conferences, ISS 2025 will bring...

International SPECTRALIS Symposium – AND BEYOND

Hemel Hempstead, Hertfordshire. UK (11 March 2025) - The International SPECTRALIS Symposium (ISS) celebrates 21 Years of Innovation in Ophthalmic Imaging at the New Heidelberg Congress Center, 13–14 June 2025, just steps away from the headquarters of Heidelberg Engineering. Recognized...

TowardPi Brings Next-Generation OCT/A to the UK

TowardPi, a fast-growing leader in ophthalmic imaging, has entered the UK market with its advanced swept-source OCT (SS-OCT) and OCT angiography (OCTA) systems. Distributed exclusively by Mainline Instruments, TowardPi is already well-established in Asia and is recognised for pioneering the...

Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership

Heidelberg Engineering announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. CCOI is a public–private forum that convenes patients, clinicians,...

Retinoblastoma in older children

Retinoblastoma is the most common ophthalmic malignancy in childhood and over 90% are diagnosed before the age of five years. It is not often suspected in older children given its rarity and unusual clinical findings which complicates the diagnosis. The...

Inherited retinal disorders now the leading cause of blindness

The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...